Sign into an existing account

Abstract

Alcohol and cannabis typically induce relaxation and sociability in healthy individuals but may trigger aggression, violence, disinhibition, and addiction in those with mental illnesses. This article explores how these substances elicit divergent behavioral responses, potentially revealing psychiatric vulnerability across disorders like schizophrenia, bipolar disorder, and others, supported by empirical evidence and neurobiological mechanisms.

Introduction

Alcohol and cannabis are widely used for their relaxing and socializing effects. In healthy individuals, these substances enhance mood without altering personality. However, in those with mental illnesses—ranging from schizophrenia to bipolar disorder, personality disorders, and beyond—they often provoke negative behaviors, such as aggression, promiscuity, or addiction.

Mental illness may be natural-born, driven by genetic factors, or acquired, such as through childhood abuse, which can disrupt neurodevelopment and increase psychiatric vulnerability (Teicher & Samson, 2016).

This article examines these contrasting effects, emphasizing mental illness broadly while highlighting schizophrenia as a well-studied case, to evaluate how substance use may reveal psychiatric conditions using facts, evidence, and logical arguments.

Effects in Healthy Individuals

In healthy people, alcohol and cannabis promote positive mood and sociability. Alcohol, a GABA agonist, enhances inhibitory neurotransmission, reducing anxiety and fostering relaxation (Valenzuela, 1997). Cannabis activates CB1 receptors, modulating dopamine and GABA to produce calmness and humor (Mechoulam & Parker, 2013). Studies show low-to-moderate alcohol doses increase social engagement (de Wit et al., 2000), while cannabis users report enhanced sociability (Green et al., 2003). These effects preserve personality, aligning with the substances’ pharmacological profiles.

Effects in Individuals with Mental Illness

In contrast, individuals with mental illnesses often exhibit severe negative reactions. Schizophrenia, a well-studied example, involves dysregulated dopamine and prefrontal cortex function, amplifying substance effects (Krystal et al., 2005). Alcohol can increase aggression in 30–50% of schizophrenic patients (Fazel et al., 2009), with cases documenting physical assaults on spouses, such as punching or choking, or verbal abuse of children, causing emotional trauma (Drake & Wallach, 2000). Cannabis, a psychosis risk factor, heightens violence, such as a schizophrenic patient attacking their child with an object during a delusion (Soyka, 2000).

Other mental illnesses show similar patterns. In bipolar disorder, alcohol can trigger manic episodes, leading to violent outbursts, like smashing household items in front of family, or hypersexual behavior with strangers (Goodwin & Jamison, 2007). Borderline personality disorder patients may exhibit cannabis-induced impulsivity, such as public verbal assaults or inappropriate sexual advances (Trull et al., 2018). Major depressive disorder can worsen with alcohol, prompting suicidal or aggressive acts, while substance-induced psychosis may mimic schizophrenic violence, complicating diagnosis (Salloum & Thase, 2000; Moore et al., 2007).

Both substances reduce inhibitions, leading to risky behaviors. In schizophrenia, alcohol-induced disinhibition causes promiscuous sex, like unprotected encounters with strangers (Coid et al., 2003). Cannabis can prompt perverted behavior, such as exhibitionism (D’Souza et al., 2009). Bipolar mania may drive compulsive sexual encounters, while personality disorders can lead to public sexual misconduct (Goodwin & Jamison, 2007; Trull et al., 2018).

Individuals with mental illnesses are also prone to addiction, not only to alcohol and cannabis but also to behaviors like gambling or compulsive sex. This stems from impaired reward processing, common across schizophrenia, bipolar disorder, and personality disorders (Chambers & Potenza, 2003). For example, schizophrenic patients may develop gambling addictions, while bipolar individuals pursue addictive sexual behaviors during mania, exacerbating their condition.

Neurobiological Mechanisms

Healthy brains process alcohol and cannabis via controlled GABA and dopamine modulation, yielding positive effects. In mental illnesses, vulnerabilities amplify adverse responses. Schizophrenia features dopamine hyperactivity and prefrontal deficits, driving psychosis (Krystal et al., 2005). Bipolar disorder involves dopamine surges during mania, while personality disorders show heightened amygdala reactivity, increasing impulsivity (Swann, 2010; Trull et al., 2018).

Depression alters serotonin and dopamine, amplifying negative reactions, and substance-induced psychosis mimics schizophrenic neurochemistry (Salloum & Thase, 2000; Moore et al., 2007). Alcohol’s GABA enhancement causes disinhibition, and cannabis’s CB1 activation triggers dopamine surges, exacerbating pathological behaviors across these conditions (D’Souza et al., 2009).

Implications for Detection

The divergent responses to alcohol and cannabis may reveal mental illness. Aggression, disinhibition, or addiction post-use could prompt clinical evaluation, complementing diagnostic tools. Schizophrenia is a key example, but patterns in bipolar disorder, personality disorders, and other conditions suggest broader applicability. Substance-induced behaviors may overlap with other disorders, requiring careful interpretation.

Conclusion

Alcohol and cannabis elicit relaxation in healthy individuals but aggression, disinhibition, and addiction in those with mental illnesses, reflecting diverse neurobiological vulnerabilities. Schizophrenia is a prominent example, but bipolar disorder, personality disorders, depression, and substance-induced psychosis also show similar patterns, including harm to loved ones, promiscuous or perverted behaviors, and addictive tendencies. These responses highlight substance use as a behavioral probe for revealing mental illness broadly, though further research is needed.

References

Chambers, R. A., & Potenza, M. N. (2003). Neurobiological aspects of addiction in schizophrenia. Journal of Psychiatric Research, 37(4), 317–330.

Coid, J., et al. (2003). Substance misuse and sexual offending in schizophrenia. British Journal of Psychiatry, 183, 304–311.

de Wit, H., et al. (2000). Effects of alcohol on mood and performance. Alcoholism: Clinical and Experimental Research, 24(7), 947–954.

D’Souza, D. C., et al. (2009). Cannabinoids and psychosis. International Review of Neurobiology, 88, 141–165.

Drake, R. E., & Wallach, M. A. (2000). Substance abuse and schizophrenia. Schizophrenia Bulletin, 26(2), 343–351.

Fazel, S., et al. (2009). Schizophrenia, substance abuse, and violent crime. JAMA, 301(19), 2016–2023.

Goodwin, F. K., & Jamison, K. R. (2007). Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. Oxford University Press.

Green, B., et al. (2003). Cannabis use and misuse: Prevalence and perceptions. Drug and Alcohol Review, 22(4), 441–446.

Krystal, J. H., et al. (2005). Neurobiological mechanisms in schizophrenia and alcoholism. American Journal of Psychiatry, 162(9), 1712–1721.

Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47.

Moore, T. H., et al. (2007). Cannabis use and risk of psychotic or affective mental health outcomes. The Lancet, 370(9584), 319–328.

Salloum, I. M., & Thase, M. E. (2000). Impact of substance abuse on the course and treatment of mood disorders. Bipolar Disorders, 2(3), 269–280.

Soyka, M. (2000). Substance misuse, psychiatric disorder and violent crime. British Journal of Psychiatry, 176, 345–350.

Swann, A. C. (2010). Mechanisms of impulsivity in bipolar disorder and related illness. Epidemiologia e Psichiatria Sociale, 19(2), 120–130.

Teicher, M. H., & Samson, J. A. (2016). Annual research review: Enduring neurobiological effects of childhood abuse and neglect. Journal of Child Psychology and Psychiatry, 57(3), 241–266.

Trull, T. J., et al. (2018). Borderline personality disorder and substance use disorders: An updated review. Borderline Personality Disorder and Emotion Dysregulation, 5, 15.

Valenzuela, C. F. (1997). Alcohol and neurotransmitter interactions. Alcohol Health and Research World, 21(2), 144–148.